“…Antibodies to Fli-1 (1:160 dilution, Santa Cruz Biotechnology, CA), CD99 (1:100 dilution; Novocastra, CA), synaptophysin (predilute, Ventana Medical Systems, Inc., AZ) , chromogranin A (predilute, Ventana Medical Systems, AZ), CD10 (predilute, Ventana Medical Systems, AZ), CD56 (predilute, Cell Marque, CA), glial fibrillary acidic protein (GFAP) (predilute, Ventana Medical Systems, AZ), neuron specific enolase (NSE) (1:150 dilution, Dako, CA; antigen retrieval not applied), S100 (predilute, Ventana Medical Systems, AZ), vimentin (predilute, Ventana Medical Systems, AZ), and cytokeratins CAM5.2 (1:80 dilution, Becton & Dickinson, CA) and AE1/AE3, (1:160, Signet Laboratories, MA; Protease1 was used for antigen retrieval), were used for immunohistochemical staining with appropriate controls. Staining was done on a BenchMark XT automated tissue staining system (Ventana Medical Systems, AZ) using validated protocols as described previously (44). Endogenous peroxidase activity was blocked by H 2 O 2 before antibody incubation.…”